Quit Smoking Drugs Market Size and Forecast 2023-2032|22nd Century Group, Alkalon A/S, Cipla Limited, Dr. Reddy’s Laboratories, GSK Plc.,

The Quit Smoking Drugs Global Market Report 2023, provides comprehensive information on the quit smoking drugs market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Quit Smoking Drugs Market’s Growth:

https://www.thebusinessresearchcompany.com/report/quit-smoking-drugs-global-market-report

The global quit smoking drugs market size is expected to grow from $8.39 billion in 2022 to $9.10 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global quit smoking drugs market size is expected to grow to $12.40 billion in 2027 at a CAGR of 8.0%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=9247&type=smp

Product innovations are a key trend in gaining popularity in the quit smoking drugs. Major companies operating in the quit-smoking drug market are focused on innovating products to strengthen their position in the market. For instance, in August 2022, Swedish Match AB, a Sweden-based tobacco company, launched ZYN Tobacco Gold, a tobacco flavored, nicotine pouch in travel retail. Tobacco Gold is available in medium (3 mg) and strong (6 mg) strengths. The pouches’ sweet tobacco flavor, which is reminiscent of dried fruit, wood, and caramel, satisfies consumer desires since tobacco has emerged as the most popular flavor to help consumers opt for reduced-risk alternatives that are both tobacco-free and smoke-free. It provides a solution for cigarette smokers who not only want to prevent the consumption of tobacco but also enjoy a nicotine kick in smoke-free environments.

The quit smoking drugs market is segmented:

1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets

2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs

3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies

North America was the largest region in the quit smoking drugs market in 2022.

The table of contents in TBRC’s quit smoking drugs market report includes:

1. Executive Summary

2. Quit Smoking Drugs Market Characteristics

3. Quit Smoking Drugs Market Trends And Strategies

4. Quit Smoking Drugs Market – Macro Economic Scenario

5. Quit Smoking Drugs Market Size And Growth

.

.

.

26. Africa Quit Smoking Drugs Market

27. Quit Smoking Drugs Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Quit Smoking Drugs Market

29. Quit Smoking Drugs Market Future Outlook and Potential Analysis

30. Appendix

Top Major Players:

• Century Group,
• Alkalon A/S
• Cipla Limited
• Dr. Reddy’s Laboratories
• GSK Plc

 

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model